SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories informs about disclosure

25 Jun 2024 Evaluate
In furtherance to the intimation captioned ‘US FDA Inspection at Company’s manufacturing facility located at Baddi, India’ dated 27th March, 2024, Alkem Laboratories has informed that the US FDA has issued an Establishment Inspection Report (EIR) for the said manufacturing facility of the Company located at Baddi, India. The Inspection has been classified as Voluntary Action Indicated (VAI) and has been closed accordingly.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5598.55 21.75 (0.39%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×